Aggregated
14% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Citizens Capital Markets
A Citizens Capital Markets analyst with 12 tracked ratings across 12 distinct tickers has a 14.3% success rate on the captured sample, covering both identified sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| CYTKCYTOKINETICS INC | 2025-04-03 | unknown | $78.00 | Aggregated |
| PGEN | 2025-03-20 | buy | $6.00 | Aggregated |
| ABVX | 2025-03-18 | buy | $33.00 | Aggregated |
| ABVXABIVAX - ADR | 2025-03-18 | unknown | $33.00 | Aggregated |
| ZVRA | 2025-03-12 | buy | $18.00 | Aggregated |
| ZVRAZEVRA THERAPEUTICS INC | 2025-03-12 | unknown | $18.00 | Aggregated |
| ESPR | 2025-03-05 | buy | $4.00 | Aggregated |
| ESPRESPERION THERAPEUTICS INC. | 2025-03-05 | unknown | $4.00 | Aggregated |
| ARGXARGEN X SE - ADR | 2025-02-28 | unknown | $701.00 | Aggregated |
| DVAXDYNAVAX TECHNOLOGIES CORP. | 2025-02-21 | unknown | $33.00 | Aggregated |
| PRTA | 2025-02-21 | buy | $80.00 | Aggregated |
| PRTAPROTHENA CORPORATION PLC | 2025-02-21 | unknown | $80.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| CYTKCYTOKINETICS INC | 1 | 2025-04-03 | Aggregated |
| PGEN | 1 | 2025-03-20 | Aggregated |
| ABVX | 1 | 2025-03-18 | Aggregated |
| ABVXABIVAX - ADR | 1 | 2025-03-18 | Aggregated |
| ZVRA | 1 | 2025-03-12 | Aggregated |
| ZVRAZEVRA THERAPEUTICS INC | 1 | 2025-03-12 | Aggregated |
| ESPR | 1 | 2025-03-05 | Aggregated |
| ESPRESPERION THERAPEUTICS INC. | 1 | 2025-03-05 | Aggregated |
| ARGXARGEN X SE - ADR | 1 | 2025-02-28 | Aggregated |
| DVAXDYNAVAX TECHNOLOGIES CORP. | 1 | 2025-02-21 | Aggregated |
| PRTA | 1 | 2025-02-21 | Aggregated |
| PRTAPROTHENA CORPORATION PLC | 1 | 2025-02-21 | Aggregated |